• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Igm Biosciences Inc (NQ: IGMS )

    17.68 +1.84 (+11.62%)
    Streaming Delayed Price Updated: 4:00 PM EDT, Sep 17, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 2,273,734
    Open 15.71
    Bid (Size) 17.68 (1)
    Ask (Size) 19.00 (5)
    Prev. Close 15.84
    Today's Range 14.94 - 22.50
    52wk Range 3.810 - 17.70
    Shares Outstanding 25,905,471
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    IGM Biosciences to Present at the Stifel 2024 Virtual Immunology and Inflammation Summit
    From IGM Biosciences, Inc.
    Via GlobeNewswire
    The Analyst Verdict: IGM Biosciences In The Eyes Of 5 Experts
    Via Benzinga

    Performance

    YTD
    +103.69%
    +103.69%
    1 Month
    +84.36%
    +84.36%
    3 Month
    +141.86%
    +141.86%
    6 Month
    +69.35%
    +69.35%
    1 Year
    +144.20%
    +144.20%

    More News

    Read More
    What 4 Analyst Ratings Have To Say About IGM Biosciences
    Via Benzinga
    IGMS Stock Earnings: IGM Biosciences Misses EPS, Misses Revenue for Q2 2024
    Via InvestorPlace
    IGM Biosciences Announces Second Quarter 2024 Financial Results and Provides Corporate Update
    From IGM Biosciences, Inc.
    Via GlobeNewswire
    In-Depth Examination Of 6 Analyst Recommendations For IGM Biosciences
    Via Benzinga
    What 5 Analyst Ratings Have To Say About IGM Biosciences
    Via Benzinga
    Where IGM Biosciences Stands With Analysts
    Via Benzinga
    Russell 2000 Index Notches Strongest Week Of Year, Hits 31-Month Highs: Outlook Is 'Clouded By Fed's Concerns Over Labor Market,' Analyst Warns
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    IGM Biosciences to Present at the Jefferies Healthcare Conference
    From IGM Biosciences, Inc.
    Via GlobeNewswire
    Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Analog Devices Posts Strong Earnings, Joins TJX, Williams-Sonoma And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Why Virios Therapeutics Shares Are Trading Lower By Around 48%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    IGMS Stock Earnings: IGM Biosciences Meets EPS, Misses Revenue for Q1 2024
    Via InvestorPlace
    IGM Biosciences Announces First Quarter 2024 Financial Results and Provides Corporate Update
    From IGM Biosciences, Inc.
    Via GlobeNewswire
    IGM Biosciences to Present at the 2024 RBCCM Global Healthcare Conference
    From IGM Biosciences, Inc.
    Via GlobeNewswire
    IGM Biosciences Announces Refocusing of Sanofi Collaboration
    From IGM Biosciences, Inc.
    Via GlobeNewswire
    IGM Biosciences to Present at the Stifel 2024 Virtual Targeted Oncology Forum
    From IGM Biosciences, Inc.
    Via GlobeNewswire
    IGMS Stock Earnings: IGM Biosciences Beats EPS, Misses Revenue for Q4 2023
    Via InvestorPlace
    IGM Biosciences Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
    From IGM Biosciences, Inc.
    Via GlobeNewswire
    CymaBay Therapeutics, ContextLogic, Snap And Other Big Stocks Moving Higher On Monday
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Big Lots Shares Are Trading Lower By Around 31%? Here Are Other Stocks Moving In Monday's Mid-Day Session
    Via Benzinga
    RBC Capital's Rating Upgrade Propels IGM Biosciences Into Immunology Limelight
    Via Benzinga
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.